A phase II study of combined fulvestrant and everolimus in patients with metastatic estrogen receptor (ER)-positive breast cancer after aromatase inhibitor (AI) failure.
Breast Cancer Res Treat
; 143(2): 325-32, 2014 Jan.
Article
in En
| MEDLINE
| ID: mdl-24327334
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Treatment Failure
/
Sirolimus
/
Aromatase Inhibitors
/
Estradiol
Type of study:
Clinical_trials
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Breast Cancer Res Treat
Year:
2014
Document type:
Article
Country of publication:
Netherlands